Abstract:Background Implantation failure is not only a major cause of early pregnancy loss, but it is also an obstacle to assisted reproductive technologies. The identification of potential circulating biomarkers for recurrent miscarriage (RM) and/or recurrent implantation failure would contribute to the development of novel diagnosis and prediction techniques. Methods MiR (miR-23a-3p, 27a-3p, 29a-3p, 100-5p, 127-3p and 486-5p) expression in the villi, decidual tissues and peripheral blood plasma and serum were validated by qPCR, and the localization of miRs in the villi and decidual tissues of RM and normal pregnancy (NP) women were detected by in situ hybridization. The invasiveness of HTR8/SVneo cells was determined using a Transwell assay. The predictive values of miRs for RM and the outcome of IVF-ET were respectively calculated by the receiver operating characteristic analysis. Results The signals of six miRs were observed in the villi and decidual tissues of RM and NP women. The villus miR-27a-3p, miR-29a-3p and miR-100-5p were significantly up-regulated, whereas miR-127-3p and miR-486-5p appeared to be down-regulated in RM women compared to NP women. The invasiveness of HTR8/SVneo cells transfected with miR-23a-3p mimics was evidently weakened, whereas that of cells transfected with miR-127-3p mimics was obviously enhanced. The peripheral blood plasma levels of miR-27a-3p, miR-29a-3p, miR-100-5p and miR-127-3p were significantly increased, whereas that of miR-486-5p was remarkably decreased in RM compared to NP women. By contrast, serum miR-23a-3p and miR-127-3p were significantly decreased, whereas that of miR-486-5p was remarkably increased. The combination of six plasma miRs levels discriminated RM with a sensitivity of 100% and a specificity of 83.3%, whereas that of six serum miRs levels showed a sensitivity of 78.3% and a specificity of 93.1%. In the IVF-ET cohort, the significantly decreased peripheral blood plasma levels of miR-23a-3p, miR-27a-3p, miR-100-5p and miR-127-3p, and the serum levels of miR-100-5p and miR-486-5p, in addition to the significantly increased serum level of miR-27a-3p, were found to be associated with the failure of ET. Moreover, the combination of plasma miR-23a-3p, miR-27a-3p, miR-29a-3p, miR-100-5p, miR-127-3p and miR-486-5p levels discriminated the outcome of IVF-ET with a sensitivity of 68.1% and a specificity of 54.1%, whereas the combination of plasma miR-127-3p and miR-486-5p levels showed a sensitivity of 50.0% and a specificity of 75.3%. Conclusions Circulating miR-23a-3p, miR-27a-3p, miR-29a-3p, miR-100-5p, miR-127-3p and miR-486-5 might be involved in RM pathogenesis and present potential diagnostic biomarkers for RM. Meanwhile, these miRs, in particular miR-127-3p and miR-486-5p, provide promising prediction indexes for the outcomes of IVF-ET.

A novel platform for discovery of differentially expressed microRNAs in patients with repeated implantation failure

Construction of Implantation Failure Related Lncrna-Mrna Network and Identification of Lncrna Biomarkers for Predicting Endometrial Receptivity

Endometrial MicroRNA Signature During the Window of Implantation Changed in Patients with Repeated Implantation Failure

Integrative Analysis of Circulating Micrornas and the Placental Transcriptome in Recurrent Pregnancy Loss

Altered microRNA Profiles of Extracellular Vesicles Secreted by Endometrial Cells from Women with Recurrent Implantation Failure

Association of the Peripheral Blood Levels of Circulating Micrornas with Both Recurrent Miscarriage and the Outcomes of Embryo Transfer in an in Vitro Fertilization Process

Identification of Differentially Expressed mRNAs and lncRNAs Contributes to Elucidation of Underlying Pathogenesis and Therapeutic Strategy of Recurrent Implantation Failure

Impact of miRNAs in the pathoetiology of recurrent implantation failure

Diverse Endometrial Mrna Signatures During the Window of Implantation in Patients with Repeated Implantation Failure

Development of a Novel Endometrial Signature Based on Endometrial microRNA for Determining the Optimal Timing for Embryo Transfer

Identification of potential biomarkers and immune infiltration characteristics in recurrent implantation failure using bioinformatics analysis

Single-cell transcriptome profiling of the human endometrium of patients with recurrent implantation failure

Construction of hub transcription factor-microRNAs-messenger RNA regulatory network in recurrent implantation failure

Integrated Transcriptomic Analysis Reveals Dysregulated Immune Infiltration and Pro-Inflammatory Cytokines in the Secretory Endometrium of Recurrent Implantation Failure Patients

[Construction of competitive endogenous RNA regulatory network and clinical verification for repeated implantation failure]

Recurrent Implantation Failure: Bioinformatic Discovery of Biomarkers and Identification of Metabolic Subtypes.

Immune profiling and RNA-seq uncover the cause of partial unexplained recurrent implantation failure

Identification of key genes, regulatory factors, and drug target genes of recurrent implantation failure (RIF)

The Clinical Characteristics of Women with Recurrent Implantation Failure

MicroRNAs in Small Extracellular Vesicles Indicate Successful Embryo Implantation During Early Pregnancy

Unraveling the H19/GAS1 axis in recurrent implantation failure: A potential biomarker for diagnosis and insight into immune microenvironment alteration